Physician profile
Morgan Stone
NPI 1497058606
$39,842.91
in general payments reported to CMS, 2019-2025
22 companies · $25.62 in 2025
The $25.62 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,598 · 2022: $13K · 2023: $20K · 2024: $1,957 · 2025: $25.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Travel and Lodging: $8,440 · Food and Beverage: $3,294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,012.44 |
| Travel and Lodging | $8,440.02 |
| Food and Beverage | $3,294.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $37,099.69 | 2021-2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $544.01 | 2021-2023 | Veozah |
| Procept Biorobotics Corporation | $478.67 | 2022-2023 | Aquabeam Robotic System |
| Pfizer INC. | $217.40 | 2022-2023 | |
| Endo Pharmaceuticals INC. | $217.10 | 2021-2023 | Xiaflex |
| Boston Scientific Corporation | $184.05 | 2022-2023 | Solyx Sis System |
| Urovant Sciences INC | $127.41 | 2021-2022 | |
| Teleflex LLC | $126.79 | 2022 | |
| Myriad Genetic Laboratories, INC. | $125.51 | 2022 | |
| Janssen Biotech, INC. | $121.09 | 2021-2022 | |
| Medtronic, INC. | $90.87 | 2021-2022 | |
| Abbvie INC. | $85.85 | 2023-2025 | |
| Urogen Pharma, INC. | $83.44 | 2021-2023 | Jelmyto |
| Myovant Sciences INC. | $79.15 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $73.75 | 2023 | Gemtesa |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $56.34 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $39.50 | 2021-2022 | |
| Olympus America INC. | $26.44 | 2023 | Itind System |
| Convatec INC. | $21.18 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.35 | 2021 | |
| Abc Home Medical Supply, INC. | $13.80 | 2022 | |
| Allergan, INC. | $11.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.